CNS myelination--role of phosphodiesterase-I/autotaxin

中枢神经系统髓鞘形成——磷酸二酯酶-I/自分泌运动因子的作用

基本信息

  • 批准号:
    6536310
  • 负责人:
  • 金额:
    $ 7.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-15 至 2004-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) The long-term goal of this project is to better understand the molecular mechanisms that determine central nervous system myelination during normal development as an approach to improve strategies for myelin repair under pathological, de-/dysmyelinating conditions, such as they occur in hereditary leukodystrophies. Since repair of the myelin sheath under such pathological conditions still remains limited, yet to be characterized molecular mechanisms are likely to significantly contribute to proper myelination. These mechanisms include those that are mediated by proteins derived from the myelin forming cells of the CNS, oligodendrocytes. The central hypothesis for the proposed studies is that soluble, oligodendrocyte-derived phosphodiesterase-I/autotaxin (PD-I alpha/ATX) is an essential component of a currently uncharacterized molecular process that regulates proper CNS myelination. PD-I alpha/ATX is released by differentiated oligodendrocytes at the developmental time-point at which oligodendrocytes are actively involved in the generation of the myelin sheath. The investigator's preliminary data indicate that the release of PD-I alpha/ATX is regulated by proteolytic cleavage. Accordingly, Specific Aim 1 will study the molecular mechanism that regulates the generation of soluble, oligodendrocyte-derived PD-I alpha/ATX. Since the primary sequence of PD-I-alpha/ATX reveals structural domains that are likely to be involved in cell-cell and/or cell-extracellular matrix interactions, potential PD-I alpha/ATX-interacting molecules of the CNS will be identified in the studies of Specific Aim 2 by using biochemical as well as molecular biological approaches. Taken together, these studies will provide novel insights into PD-I alpha/ATX-mediated events that control CNS myelination during development and that may stimulate remyelination in de-/dysmyelinating diseases.
描述:(申请者提供)这个项目的长期目标是更好地理解决定中枢神经的分子机制 系统在正常发育过程中的髓鞘形成是一种改善的方法 病理性脱髓鞘/髓鞘损伤下髓鞘修复的策略 遗传性脑白质营养不良等病症。自修以来 在这样的病理条件下,髓鞘的数量仍然有限, 尚待确定的分子机制可能会显著 有助于适当的髓鞘形成。这些机制包括 由来自中枢神经系统髓鞘形成细胞的蛋白质介导, 少突胶质细胞。 拟议研究的中心假设是,可溶的, 少突胶质细胞来源的磷酸二酯酶-I/自体趋化蛋白(PD-Iα/ATX)是一种 一种目前尚未确定的分子过程的基本组成部分 调节适当的中枢神经系统髓鞘形成。PD-Iα/ATX由 在发育时间点分化的少突胶质细胞 少突胶质细胞积极参与髓鞘的形成。 调查人员的初步数据表明,Pd-I的释放 Alpha/ATX受蛋白水解性切割调控。因此,具体目标1 将研究调节可溶性物质产生的分子机制, 少突胶质细胞来源的PD-Iα/ATX。因为主序列是 PD-I-α/ATX揭示了可能参与的结构域 细胞-细胞和/或细胞-细胞外基质相互作用,潜在的PD-I 将在研究中确定中枢神经系统的Alpha/ATX相互作用分子 通过使用生化和分子生物学来实现特定的目的2 接近了。综上所述,这些研究将为 PD-Iα/ATX介导的在发育过程中控制中枢神经系统髓鞘形成的事件 这可能会刺激脱髓鞘/髓鞘障碍疾病的重新髓鞘形成。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BABETTE FUSS其他文献

BABETTE FUSS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BABETTE FUSS', 18)}}的其他基金

LPA6 signaling as a modulator of oligodendrocyte differentiation and CNS myelination
LPA6 信号作为少突胶质细胞分化和 CNS 髓鞘形成的调节剂
  • 批准号:
    10288115
  • 财政年份:
    2021
  • 资助金额:
    $ 7.25万
  • 项目类别:
47th Annual Meeting of the American Society for Neurochemistry
第 47 届美国神经化学学会年会
  • 批准号:
    9123121
  • 财政年份:
    2016
  • 资助金额:
    $ 7.25万
  • 项目类别:
Glutamate transporters as regulators of CNS myelination
谷氨酸转运蛋白作为中枢神经系统髓鞘形成的调节剂
  • 批准号:
    8999028
  • 财政年份:
    2015
  • 资助金额:
    $ 7.25万
  • 项目类别:
CaMKIIbeta: a regulator of CNS myelination
CaMKIIbeta:中枢神经系统髓鞘形成的调节因子
  • 批准号:
    8707006
  • 财政年份:
    2014
  • 资助金额:
    $ 7.25万
  • 项目类别:
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
PD-Ialpha/ATX 在前脑少突胶质细胞规范和迁移中的作用
  • 批准号:
    7429857
  • 财政年份:
    2008
  • 资助金额:
    $ 7.25万
  • 项目类别:
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
PD-Ialpha/ATX 在前脑少突胶质细胞规范和迁移中的作用
  • 批准号:
    7595242
  • 财政年份:
    2008
  • 资助金额:
    $ 7.25万
  • 项目类别:
PD-Ialpha/ATX's role for forebrain oligodendrocyte specification and migration
PD-Ialpha/ATX 在前脑少突胶质细胞规范和迁移中的作用
  • 批准号:
    7796807
  • 财政年份:
    2008
  • 资助金额:
    $ 7.25万
  • 项目类别:
Guidance of Oligodendrocyte Processes: The Role of Local Protein Synthesis
少突胶质细胞过程的指导:局部蛋白质合成的作用
  • 批准号:
    7210043
  • 财政年份:
    2007
  • 资助金额:
    $ 7.25万
  • 项目类别:
Guidance of Oligodendrocyte Processes: The Role of Local Protein Synthesis
少突胶质细胞过程的指导:局部蛋白质合成的作用
  • 批准号:
    7350909
  • 财政年份:
    2007
  • 资助金额:
    $ 7.25万
  • 项目类别:
Mechanisms in CNS myelination: Role of PD-lalpha/ATX
CNS 髓鞘形成机制:PD-lalpha/ATX 的作用
  • 批准号:
    9332470
  • 财政年份:
    2004
  • 资助金额:
    $ 7.25万
  • 项目类别:

相似海外基金

Say Yes to NO: The Next Generation Scaffolds with Localized and Sustained Nitric Oxide (NO) Delivery for Central Nervous System Regeneration
对“否”说“是”:具有局部和持续一氧化氮 (NO) 输送的下一代支架,用于中枢神经系统再生
  • 批准号:
    EP/X027198/2
  • 财政年份:
    2024
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Fellowship
Elucidation of metabolic control mechanism by FGF21-mediated central nervous system signaling in neonatal period
阐明新生儿期 FGF21 介导的中枢神经系统信号传导的代谢控制机制
  • 批准号:
    23K10836
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Strategy to Attack Coronavirus Infections Brain Fog-Central Nervous System Sequelae Using a Novel Patented Technology
利用新型专利技术对抗冠状病毒感染脑雾-中枢神经系统后遗症的策略
  • 批准号:
    23K10453
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of immune cells protecting from lethal viral infection in the central nervous system
鉴定中枢神经系统免受致命病毒感染的免疫细胞
  • 批准号:
    22KJ1176
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Central nervous system inflammation due to a high-fat diet and changes in exercise volume - effects on obesity
高脂肪饮食和运动量变化引起的中枢神经系统炎症——对肥胖的影响
  • 批准号:
    23K10646
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
  • 批准号:
    10555126
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
2023 Central Nervous System Injury and Repair Gordon Research Conference and Seminar
2023中枢神经系统损伤与修复戈登研究会议暨研讨会
  • 批准号:
    10753737
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
Maladaptive Remodeling of the Neuromuscular Synapse Following Central Nervous System Injury
中枢神经系统损伤后神经肌肉突触的适应不良重塑
  • 批准号:
    10569935
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
Effects of Central Nervous System Agents on Next Generation Development via Changes in Sperm DNA Methylation
中枢神经系统药物通过精子 DNA 甲基化的变化对下一代发育的影响
  • 批准号:
    23K19438
  • 财政年份:
    2023
  • 资助金额:
    $ 7.25万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了